Cargando…

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study

BACKGROUND: Neurological complications due to chikungunya virus (CHIKV) infection have been described in different parts of the world, with children being disproportionately affected. However, the burden of CHIKV-associated neurological disease in Africa is currently unknown and given the lack of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyamwaya, Doris K., Otiende, Mark, Mwango, Lilian, Kariuki, Symon M., Otieno, Berrick, Omuoyo, Donwilliams O., Githinji, George, Kitsao, Barnes S., Karanja, Henry K., Gitonga, John N., de Laurent, Zaydah R., Davies, Alun, Mwarumba, Salim, Agoti, Charles N., Thumbi, Samuel M., Hamaluba, Mainga M., Newton, Charles R., Bejon, Philip, Warimwe, George M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135332/ https://www.ncbi.nlm.nih.gov/pubmed/35550620 http://dx.doi.org/10.1371/journal.pmed.1003994

Ejemplares similares

Endemic chikungunya fever in Kenyan children: a prospective cohort study
por: Nyamwaya, Doris K., et al.
Publicado: (2021)

Congenital microcephaly unrelated to flavivirus exposure in coastal Kenya
por: Barsosio, Hellen C., et al.
Publicado: (2019)

Urban Ecology of Arboviral Mosquito Vectors Along the Kenyan Coast
por: Karisa, Jonathan, et al.
Publicado: (2021)

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis
por: Nyamwaya, Doris K., et al.
Publicado: (2022)

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
por: Githinji, George, et al.
Publicado: (2021)

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
por: Nyagwange, James, et al.
Publicado: (2023)

Complete Genome Sequences of Dengue Virus Type 2 Strains from Kilifi, Kenya
por: Kamau, Everlyn, et al.
Publicado: (2019)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
por: Nyagwange, James, et al.
Publicado: (2022)

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study
por: Agoti, Charles N, et al.
Publicado: (2022)

Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast
por: Agoti, Charles N., et al.
Publicado: (2021)

Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya
por: Orangi, Stacey, et al.
Publicado: (2021)

Vectorial capacity and TEP1 genotypes of Anopheles gambiae sensu lato mosquitoes on the Kenyan coast
por: Bartilol, Brian, et al.
Publicado: (2022)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
por: Jao, Irene, et al.
Publicado: (2020)

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity
por: Kapulu, Melissa C., et al.
Publicado: (2019)

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021)

COVID-19 transmission dynamics underlying epidemic waves in Kenya
por: Brand, Samuel P. C., et al.
Publicado: (2021)

An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams
por: Mohammed, Khadija Said, et al.
Publicado: (2022)

Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
por: Kapulu, Melissa C., et al.
Publicado: (2021)

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
por: Kimathi, Derick, et al.
Publicado: (2023)

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
por: Kapulu, Melissa C., et al.
Publicado: (2022)

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
por: Gallagher, Katherine E., et al.
Publicado: (2023)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
por: Nyagwange, James, et al.
Publicado: (2022)

Epidemiological and evolutionary dynamics of influenza B virus in coastal Kenya as revealed by genomic analysis of strains sampled over a single season
por: Nyasimi, Festus M, et al.
Publicado: (2020)

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
por: Juan-Giner, Aitana, et al.
Publicado: (2021)

The utility of Escherichia coli as a contamination indicator for rural drinking water: Evidence from whole genome sequencing
por: Nowicki, Saskia, et al.
Publicado: (2021)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
por: Lucinde, Ruth K., et al.
Publicado: (2022)

Detection of SARS-CoV-2 variant 501Y.V2 in Comoros Islands in January 2021
por: N. Agoti, Charles, et al.
Publicado: (2021)

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial
por: Wamae, Kevin, et al.
Publicado: (2023)

Incidence, causes and phenotypes of acute seizures in Kenyan children post the malaria-decline period
por: Serem, George K., et al.
Publicado: (2015)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
por: Etyang, Anthony O., et al.
Publicado: (2022)

A27 Using whole genome sequence data and minority variant profiles to elucidate transmission patterns during RSV household outbreaks
por: Githinji, George, et al.
Publicado: (2017)

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
por: Bottomley, C., et al.
Publicado: (2021)

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control
por: Snow, Robert W., et al.
Publicado: (2015)

Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
por: Kimathi, Derick, et al.
Publicado: (2019)

The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children
por: Warimwe, George M., et al.
Publicado: (2013)

Genome Sequences of Human Coronavirus OC43 and NL63, Associated with Respiratory Infections in Kilifi, Kenya
por: Kamau, Everlyn, et al.
Publicado: (2019)

Genomic epidemiology and evolutionary dynamics of respiratory syncytial virus group B in Kilifi, Kenya, 2015–17
por: Kamau, Everlyn, et al.
Publicado: (2020)

Using cross-species vaccination approaches to counter emerging infectious diseases
por: Warimwe, George M., et al.
Publicado: (2021)

Evaluating the performance of tools used to call minority variants from whole genome short-read data
por: Said Mohammed, Khadija, et al.
Publicado: (2018)

Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast
por: Kariuki, Symon M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k23haeoj2k4iqm8tgqtkr2dj2n